Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureEren Yeh
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local citing links have been materialized yet.
Dual-Layer Spectral CT-Based Models for the Differential Diagnosis of Breast Lesions
10.1093/jbi/wbag018 · 2026
Improvement of Breast Cancer Detection Using Dual-Layer Spectral CT
10.3390/diagnostics14141560 · 2024
Comparison of contrast-enhanced CT, dual-layer detector spectral CT, and whole-body MRI in suspected metastatic breast cancer: a prospective diagnostic accuracy study
10.1007/s00330-021-08041-2 · 2021
Contrast-enhanced dedicated breast CT: initial clinical experience
10.1148/radiol.10092311 · 2010
Dedicated Breast CT: Getting Ready for Prime Time
10.1093/jbi/wbae043 · 2024
Dual-Energy CT for Locoregional Staging of Breast Cancer: Preliminary Results
10.2214/ajr.18.20953 · 2020
Pretreatment dual-energy CT versus diffusion-weighted imaging for predicting pathologic complete response to neoadjuvant chemotherapy in breast cancer
10.1186/s12880-026-02219-0 · 2026
Correlation Between Quantitative Parameters Obtained by Dual Energy Spectral CT and Prognostic Histopathological Factors and Biomarkers in Breast Cancer
10.1016/j.clbc.2024.01.022 · 2024
Assignment of the Biological Identity of Breast Masses in Contrast-enhanced Spectral Computed Tomography Examinations of Chest Carried Out in Clinical Routine Diagnostics
10.1097/rli.0000000000001215 · 2026
Spectral computed tomography (CT) in breast lesion evaluation: clinical utility and imaging spectrum-a pictorial review
10.1016/j.crad.2025.107161 · 2026
Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR
10.1016/j.jacr.2023.04.002 · 2023
ACR Appropriateness Criteria(R) Female Breast Cancer Screening: 2025 Update
10.1016/j.jacr.2025.08.044 · 2025
Breast cancer staging with contrast-enhanced imaging. The benefits and drawbacks of MRI, CEM, and dedicated breast CT
10.1016/j.ejrad.2025.112013 · 2025
Dual-Energy CT as a Well-Established CT Modality to Reduce Contrast Media Amount: A Systematic Review from the Computed Tomography Subspecialty Section of the Italian Society of Radiology
10.3390/jcm13216345 · 2024
Image quality of opportunistic breast examinations in photon-counting computed tomography: A phantom study
10.1016/j.ejmp.2024.103378 · 2024
CT Radiation Dose Reduction With Preserved Diagnostic Performance: How Far Have We Come Over 25 Years?
10.2214/ajr.25.34450 · 2026
Photon-counting detector CT in oncology: a new era of cancer imaging
10.1186/s13244-025-02176-2 · 2026
Diagnostic Accuracy of Contrast-Enhanced Thoracic Photon-Counting Computed Tomography for Opportunistic Locoregional Staging of Breast Cancer Compared With Digital Mammography: A Prospective Trial
10.1097/rli.0000000000001051 · 2024
Staging of breast cancer in the breast and regional lymph nodes using contrast-enhanced photon-counting detector CT: accuracy and potential impact on patient management
10.1093/bjr/tqad042 · 2024
Prone Photon-counting Computed Tomography With Iodine Mapping for Differentiating Breast Masses: A Prospective Study
10.1097/rli.0000000000001263 · 2025
No additional external references are available.